Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Sold rose from $222.7M to $243.8M (+$21.1M) in 365 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-10-01 | D/A | $222.7M | 1 | |
| 2025-10-01 | D/A | $243.8M | 1 | +$21.1M |
| 2026-09-30 | D/A | $260.3M | 2 | +$16.5M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$16.5M, +1 investor) in 364 days since the previous filing.
| Alberto Luigi Radice-Fossati | Executive Officer, Promoter |
| Peter Gideon Lesburg | Executive Officer, Promoter |
| Liudmila Minchenia | Executive Officer, Promoter |
| Tjebbe de Jong | Executive Officer, Promoter |
| N/A RELIF GP S.a r.l. | Executive Officer, Promoter |
Signed by Peter Lesburg, Manager of the GP of the Issuer.
Relevant to: Fund audit & tax, Fund administrator, Placement agent / capital introduction, Custodian / prime broker.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
